How To Control Indian Diabetes Growth
Bio Spectrum|BioSpectrum India Dec 2024
World Diabetes Day, observed on November 14, reminds us of the growing impact of diabetes on global health and the urgent need for collective action to prevent, diagnose, and manage this chronic condition. In 2024, the theme 'Breaking Barriers, Bridging Gaps' underscores the critical importance of accessible, high-quality diabetes care, especially for underrepresented communities. The Government of India has taken many measures intending to reduce the prevalence of diabetes and alleviate its long-term complications, contributing to a healthier future for all citizens.
Narayan Kulkarni
How To Control Indian Diabetes Growth

An estimated 828 million adults (those aged AR 18 years and older) had diabetes in 2022, an increase of 630 million from 1990. Of these, 420 million were women and 408 million were men. India (212 million) and China (148 million) accounted for the largest proportion of this number, followed by the USA, Pakistan, Indonesia, and Brazil, according to The Lancet report published on November 13, 2024. From 1990 to 2022, the agestandardised prevalence of diabetes increased in 131 countries for women and in 155 countries for men with a posterior probability of more than 0.80.

The report, which used 1108 studies conducted across the world from 1980 to 2022 with 141 million participants aged 18 years or older, noted that a total of 445 million adults aged 30 years or older with diabetes were not treated with oral hypoglycaemic drugs nor insulin, 3-5 times the number in 1990 (129 million). 30 per cent of those with untreated diabetes (133 million) were in India, more than 50 per cent greater than the next largest number of people with untreated diabetes, which was in China (78 million) because treatment coverage was higher in China than in India.

The Lancet reported that an important driver of the rise in diabetes, and its variation across countries, is obesity. In addition to obesity, the consumption of specific foods might influence the risk of diabetes. For example, yoghurt and possibly some other forms of dairy, whole grains, and green leafy vegetables reduce the risk of diabetes, whereas refined carbohydrates, including sugar-sweetened beverages, increase this risk.

この記事は Bio Spectrum の BioSpectrum India Dec 2024 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

この記事は Bio Spectrum の BioSpectrum India Dec 2024 版に掲載されています。

7 日間の Magzter GOLD 無料トライアルを開始して、何千もの厳選されたプレミアム ストーリー、9,000 以上の雑誌や新聞にアクセスしてください。

BIO SPECTRUMのその他の記事すべて表示
Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities
Bio Spectrum

Agilent releases nextgen HPLC systems with enhanced automation and sustainability capabilities

Agilent Technologies Inc. has announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions.

time-read
1 min  |
BioSpectrum India Dec 2024
Univercells Technologies launches miniaturised scale-X Nexo Bioreactor
Bio Spectrum

Univercells Technologies launches miniaturised scale-X Nexo Bioreactor

Univercells Technologies has announced the launch of its latest innovation, the scale-X nexo bioreactor.

time-read
1 min  |
BioSpectrum India Dec 2024
Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics
Bio Spectrum

Thermo Fisher and Telangana to establish Bioprocess Design Centre for novel biotherapeutics

Thermo Fisher Scientific has announced the signing of a Memorandum of Understanding (MoU) with the Government of Telangana to establish a Bioprocess Design Centre (BDC) in Genome Valley, Hyderabad.

time-read
1 min  |
BioSpectrum India Dec 2024
VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors
Bio Spectrum

VFL Sciences announces launch of GreatFlo Parallel Bioreactors and Fermentors

Chennai-based VFL Sciences has announced the launch of GreatFlo Parallel, a range of seamlessly parallel Bioreactors and Fermentors at the IKMC 2024 event organised by IKP Knowledge Park at Hyderabad recently, by Dr Jitendra Kumar, Managing Director, BIRAC.

time-read
1 min  |
BioSpectrum India Dec 2024
Avantor opens new innovation centre for solving life science's biggest challenges
Bio Spectrum

Avantor opens new innovation centre for solving life science's biggest challenges

Avantor, Inc., a leading global provider of mission-critical products and services to customers in the life sciences and advanced technology industries, has announced the opening of its new flagship Bridgewater Innovation Centre.

time-read
1 min  |
BioSpectrum India Dec 2024
Waters unveils new software to deliver lab-centric business intelligence
Bio Spectrum

Waters unveils new software to deliver lab-centric business intelligence

Waters Corporation has announced the launch of waters connect Data Intelligence software, a new cloud-based application that helps customers in regulated industries improve how they access, organise, analyse, and drive productivity from laboratory information.

time-read
1 min  |
BioSpectrum India Dec 2024
INST develops unique drug delivery method to improve treatment of brain TB
Bio Spectrum

INST develops unique drug delivery method to improve treatment of brain TB

Researchers at the Institute of Nano Science and Technology (INST), Mohali, have created a unique way to deliver Tuberculosis (TB) medicines directly to the brain bypassing the challenging blood-brain barrier (BBB) that limits the effectiveness of many brain TB medicines.

time-read
1 min  |
BioSpectrum India Dec 2024
New way to create hydrogels from viral protein fragments for improving drug delivery
Bio Spectrum

New way to create hydrogels from viral protein fragments for improving drug delivery

Researchers from Bose Institute, an autonomous institute of the Department of Science and Technology (DST), in Kolkata, have discovered a new way to create hydrogels using tiny protein fragments of just five amino acids from the SARS-CoV-1 virus, that could help improve targeted drug delivery & reduce side effects.

time-read
1 min  |
BioSpectrum India Dec 2024
Lupin appoints Claus Jepsen as President, Global Specialty
Bio Spectrum

Lupin appoints Claus Jepsen as President, Global Specialty

Global pharma major Lupin has announced the appointment of Claus Jepsen as President, Global Specialty.

time-read
1 min  |
BioSpectrum India Dec 2024
Shyamakant Giri to join as CEO of Gland Pharma
Bio Spectrum

Shyamakant Giri to join as CEO of Gland Pharma

Gland Pharma’s Board has approved the appointment of Shyamakant Giri, as the new Chief Executive Officer (CEO) of the company.

time-read
1 min  |
BioSpectrum India Dec 2024